Jan. 15, 2014—Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
Aug. 15, 2013—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.
May. 30, 2013—Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.
Nov. 12, 2012—Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.
Oct. 31, 2012—The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells.
Oct. 10, 2012—Additional volunteers are needed Oct. 17 and 18 to assist with this year’s Flulapalooza, where Vanderbilt University and Medical Center faculty, staff, students and volunteers can quickly receive their flu vaccination during a mass flu vaccination plan. While exempt employees are encouraged to participate as volunteers, non-exempt employees also can participate in this event. All...
Oct. 3, 2012—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination plan that last year more than doubled the then-world record for the total number of vaccinations given in an eight-hour period.
Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.
Apr. 27, 2012—New information may help speed development of a vaccine or treatment for dengue fever.
Apr. 13, 2012—A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.
Feb. 15, 2012—New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.
Dec. 19, 2011—Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases.